AbCellera Biologics Inc.

ABCL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001703057

SEC filings (opens in a new tab)

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding AbCellera Biologics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of ABCL: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	139	3	146	+10
Shares	105.6M	1.81M	113.9M	+10.1M (+9.7%)
Value	$274.6M	$4.65M	$333.9M	+$64.0M (+23.7%)

3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ABCL in Q4 2024
Institution	Shares	Value	% of portfolio
Capital World Investors	7,933,613	$23.2M	0.00%
Guardian Partners Inc.	1,786,414	$5.41M	0.55%
ExodusPoint Capital Management, LP	281,795	$826.0K	0.01%
PEAK6 LLC	199,995	$586.0K	0.02%
Graham Capital Management, L.P.	103,610	$303.6K	0.01%
XTX Topco Ltd	91,754	$268.8K	0.02%
Moloney Securities Asset Management, LLC	90,400	$264.9K	0.04%
Centiva Capital, LP	62,899	$184.3K	0.01%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys	21,664	$63.5K	0.00%
Rpo LLC	20,937	$61.3K	0.08%
Raymond James Financial Inc	19,501	$57.1K	0.00%
IMG Wealth Management, Inc.	19,000	$55.7K	0.05%
Diametric Capital, LP	18,104	$53.0K	0.04%
Boothbay Fund Management, LLC	15,703	$46.0K	0.00%
Mariner, LLC	14,540	$42.4K	0.00%
Balyasny Asset Management LLC	13,521	$39.6K	0.00%
State of New Jersey Common Pension Fund D	12,232	$35.8K	0.00%
DKM Wealth Management, Inc.	10,000	$29.3K	0.03%
GF Fund Management Co. Ltd.	6,202	$18.2K	0.00%
Quantbot Technologies LP	5,739	$16.8K	0.00%
BNP Paribas Arbitrage, SA	4,726	$13.8K	0.00%
SBI Securities Co., Ltd.	2,391	$7.01K	0.00%
Skopos Labs, Inc.	634	$1.86K	0.00%
UMA Financial Services, Inc.	593	$1.74K	0.00%
R Squared Ltd	470	$1.38K	0.00%
CVA Family Office, LLC	339	$993	0.00%
CKW Financial Group	50	$0	0.00%

Sold out (17)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ABCL in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
D. E. Shaw & Co., Inc.	420,240	$1.09M
Citizens Financial Group Inc	311,890	$810.9K
EPIQ Capital Group, LLC	86,291	$224.4K
Handelsbanken Fonder AB	69,900	$182.0K
Stratos Wealth Advisors, LLC	45,500	$118.3K
National Asset Management, Inc.	34,000	$88.4K
GTS Securities LLC	21,479	$55.8K
Cambridge Investment Research Advisors, Inc.	15,705	$41.0K
Searle & Co.	13,900	$36.1K
Kestra Advisory Services, LLC	13,818	$35.9K
LPL Financial LLC	13,313	$34.6K
Guggenheim Capital LLC	10,362	$26.9K
Arcadia Investment Management Corp	10,000	$26.0K
Baader Bank INC	12,000	$22.4K
Bryn Mawr Trust Co	5,968	$15.5K
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	2,300	$5.98K
FMR LLC	750	$1.95K

Not filed for Q4 2024 yet (3)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABCL in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Guardian Capital Advisors LP	1,786,414	$4.59M
Raymond James & Associates	12,458	$32.4K
Raymond James Financial Services Advisors, Inc.	10,552	$27.4K